Evolus (EOLS) Profit After Tax (2017 - 2026)
Evolus' (EOLS) quarterly Profit After Tax came in at -$10.8 million in Q1 2026, up 42.65% YoY from -$7.6 million in Q1 2025, and down 1328.21% on a QoQ basis from $879000.0 in Q4 2025.
Evolus (EOLS) Profit After Tax (2017 - 2026) Analysis & Trends
Evolus (EOLS) has 10 years of Profit After Tax data on file, last reported at -$10.8 million in Q1 2026.
- Quarterly Profit After Tax rose 42.65% year-over-year to -$10.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$42.3 million (up 25.34% YoY) and the FY2025 annual result came in at -$50.9 million, changed 0.01% from the prior year.
- Profit After Tax slipped to -$10.8 million in Q1 2026, from $879000.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $879000.0 in Q4 2025 to a low of -$23.5 million in Q2 2022.
- A 5-year average of -$14.6 million and a median of -$15.3 million in 2025 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax plunged 373.41% — and 2025, when it jumped 112.09%.
- Tracing EOLS's Profit After Tax over 5 years: stood at -$13.2 million in 2022, then gained by 12.17% to -$11.6 million in 2023, then soared by 37.13% to -$7.3 million in 2024, then jumped by 112.09% to $879000.0 in 2025, then tumbled by 1328.21% to -$10.8 million in 2026.
- The last three Profit After Tax figures came in at -$10.8 million (Q1 2026), $879000.0 (Q4 2025), and -$15.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Evolus | 550.84 Mn | 505.67 Mn | 57.18 Mn | -8.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.30 Mn |
| Mar 31, 2026 | -10.80 Mn |
| Dec 31, 2025 | 879,000.00 |
| Sep 30, 2025 | -15.28 Mn |
| Jun 30, 2025 | -17.14 Mn |
| Mar 31, 2025 | -18.83 Mn |
| Dec 31, 2024 | -7.27 Mn |
| Sep 30, 2024 | -19.26 Mn |
| Jun 30, 2024 | -11.35 Mn |
| Mar 31, 2024 | -13.11 Mn |
| Dec 31, 2023 | -11.56 Mn |
| Sep 30, 2023 | -16.92 Mn |
| Jun 30, 2023 | -18.14 Mn |
| Mar 31, 2023 | -14.79 Mn |
| Dec 31, 2022 | -13.16 Mn |
| Sep 30, 2022 | -20.28 Mn |
| Jun 30, 2022 | -23.47 Mn |
| Mar 31, 2022 | -17.50 Mn |
| Dec 31, 2021 | -18.18 Mn |
| Sep 30, 2021 | -19.43 Mn |